What is the global market size of the Interventional Cardiology Market?

Global Interventional Cardiology Devices Market size was valued at USD 12.91 billion in 2021 and is poised to grow from USD 13.85 billion in 2022 to USD 24.34 billion by 2030, growing at a CAGR of 7.3% in the forecast period (2023-2030).

Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35A2171 | Region: Global | Published Date: December, 2024
Pages: 242 | Tables: 67 | Figures: 65

Interventional Cardiology Devices Market Dynamics

Interventional Cardiology Devices Market Driver

Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

Interventional Cardiology Devices Market Restraint

To meet changing customer needs, the complicated regulatory standards for medical device affiliation are modified. These regulations are difficult because of the legal factors involved. Medical device performance and quality must be rigorously scrutinised in order to ensure public safety. As a result, the stringent and complex standards used to certify medical devices may limit market growth.

Interventional Cardiology Devices Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Interventional Cardiology Devices Market size was valued at USD 13.85 Billion in 2023 and is poised to grow from USD 14.86 Billion in 2024 to USD 26.12 Billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

Global interventional cardiology devices market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Abbott Laboratories ', 'B. Braun Melsungen AG ', 'Boston Scientific Corporation ', 'Medtronic PLC ', 'Terumo Corporation ', 'Biotronik SE & Co. KG ', 'Biosensors International Group Ltd ', 'ACIST Medical Systems ', 'Cardinal Health, Inc. ', 'Cook Medical Inc. ', 'Koninklijke Philips N.V. ', 'Edwards Lifesciences Corporation ', 'Nano Therapeutics Pvt. Ltd. ', 'AngioDynamics, Inc. ', 'Inari Medical, Inc. ', 'Genetesis, Inc. ', 'OptiMed Medical Instruments GmbH ', 'Meril Life Sciences Pvt. Ltd. ', 'OrbusNeich Medical'

Consumption of saturated fats, excessive salt, alcohol consumption, and smoking are all poor lifestyle practises that significantly raise the risk of coronary artery disease, which is expected to accelerate of the interventional cardiology devices market. Furthermore, high tobacco consumption and a lack of exercise motivate market growth. Furthermore, physical inactivity can increase the risk of obesity and coronary artery disease.

Obesity is increasing the prevalence of cardiovascular disease. Furthermore, the incidence of coronary artery disease has increased as a result of changing lifestyles characterised by smoking, heavy alcohol consumption, and inactivity. With the use of interventional cardiology instruments, cardiologists can perform treatments quickly and without causing complications.

North America is expected to lead the global interventional cardiology devices market throughout the forecast period due to the influence of advanced healthcare infrastructure, supportive government product development initiatives, and high patient awareness levels. According to the American Heart Association, by 2035, approximately 45% of the US population will be affected by heart disease as a result of factors such as high obesity, high smoking, and unhealthy lifestyles, which can cause a heart attack and other related issues. In addition, 1.5 million Americans are treated for diabetes each year in the United States alone. Incidence of diabetes is increasing primarily due to an increase in the geriatric population; it is guesstimated that 25% of all geriatric individuals (aged 60 and above) in the United States have diabetes.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Interventional Cardiology Devices Size, Share, Growth Analysis, By Product (Coronary Stents, Structural Heart Devices), By End User (Hospitals & ASCS, Catheterization Labs & Others), By Region - Industry Forecast 2025-2032

Interventional Cardiology Devices Market Dynamics

Interventional Cardiology Devices Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Interventional Cardiology Devices Market?

Who are the key vendors in the Interventional Cardiology Devices Market?

What is the key driver of Interventional Cardiology Devices Market?

What is the key market trend for Interventional Cardiology Devices Market?

Which region accounted for the largest share in Interventional Cardiology Devices Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300